Therapy for Graves' ophthalmopathy.
- Author:
Jianguo ZHENG
1
;
Xia ZHANG
;
Rixiang GONG
;
Ji WANG
;
Tianzhi TAN
Author Information
1. Department of Nuclear Medicine, Beijing Hospital, Beijing, 610041, China.
- Publication Type:Journal Article
- MeSH:
Combined Modality Therapy;
Exophthalmos;
etiology;
radiotherapy;
therapy;
Graves Disease;
complications;
radiotherapy;
therapy;
Humans;
Immunoglobulins;
therapeutic use;
Prednisolone;
therapeutic use
- From:
Journal of Biomedical Engineering
2004;21(5):876-879
- CountryChina
- Language:Chinese
-
Abstract:
Graves' ophthalmopathy (GO) is also called thyroid-related eye disease, infiltrative ophthalmopathy, which is related with the autoimmunity of thyroid, especially hyperthyroidism. Its morbidity ragnes from five percent to ten percent of hyperthyroidism, and the morbidity of male patients is higher than that of the female patients. The treatment of severe GO is a difficult task for doctors. The therapeutic effect is not always satisfactory. In order to solve this knotty problem, researchers have been devoting themselves to the development of new therapeutic methods. Here, the development of the therapies for GO is introduced, and the trends of treatments are prospected.
